Condition

Venous Thromboembolism

ClinicalTrials.gov condition label

Clinical trials55

Recruiting5

Common interventions25

Lead sponsors shown15

Clinical trials

55 shown

Pulmonary Embolism in Patients With Acute Heart Failure (PEHF Study)NCT07499661 · 2026-07-15

Statins to Prevent Cancer Associated Blood ClotsNCT07303816 · 2026-06-11

The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue MorbidityNCT06494878 · 2026-06-04

The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic CancerNCT06861088 · 2025-12-19

Development and Application of a Thrombosis Risk Prediction Model in Lung Cancer Patients Treated With Immune Checkpoint InhibitorsNCT06950697 · 2019-01-01

Edoxaban Versus Apixaban in Cancer-Associated Venous ThromboembolismNCT07852637 · 2026-11-01

NOT_YET_RECRUITING

Evaluation of Anti-Xa Activity in Patients With Severe Obesity After Subcutaneous Injection of Enoxaparin for Antithrombotic Prophylaxis at Two Different Sites.NCT07213713 · 2025-10-01

NOT_YET_RECRUITING

Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer SurgeryNCT06451003 · 2024-07-01

ACTIVE_NOT_RECRUITING

Comparison of the Risk of Venous Thromboembolism (i.e., Blood Clots in the Veins) and Bleeding Events in a Population of Obese Patients Receiving Higher-Dose or Extended-Duration Versus Conventional-Dose or Conventional-Duration of Prophylaxis (i.e., Preventive Treatment) With EnoxaparinNCT05819125 · 2023-04-25

A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTENCT05171075 · 2022-09-27

A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTENCT05171049 · 2022-05-05

Impact of COVID-19 Vaccines on Cerebrovascular HealthNCT04992195 · 2021-07-05

Enoxaparin Versus Placebo for Venous Thromboembolism Prevention in Low Risk Cancer Patients After Surgical Procedures: a Randomized, Double Blind, Placebo Controlled Clinical Trial Pilot StudyNCT03988231 · 2021-07-01

Pilot PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue MorbidityNCT04153760 · 2020-10-07

Improving Safety of Diagnosis and Therapy in the Inpatient SettingNCT04393909 · 2019-07-01

The Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort StudyNCT03835780 · 2019-02-01

Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer (PROVE)NCT03090880 · 2018-09-14

Venous Thromboembolism in Advanced Lung CancerNCT03581708 · 2018-07-01

LIFE - Lung Cancer, Immunotherapy, Frailty, EffectNCT03870464 · 2018-04-01

ACTIVE_NOT_RECRUITING

WAVe Study - Weight Adjusted Dalteparin for Patients Over 90 kg With Acute Cancer Associated Venous ThromboembolismNCT03297359 · 2018-03-21

Study of Prophylactic Effect of Rivaroxaban on Venous Thromboembolism in AECOPDNCT03277001 · 2017-10-01

A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous ThromboembolismNCT03240120 · 2017-09-01

Incidence of Venous Thromboembolism in Patients Undergoing Major Esophageal ResectionNCT03115541 · 2017-07-10

PREvention of VENous ThromboEmbolism Following Radical ProstatectomyNCT03006562 · 2017-07-01

Drug Interaction Study of Apixaban With Cyclosporine and TacrolimusNCT03083782 · 2017-04-18

Hemostatic Profiles of Endocrine Therapies for Breast CancerNCT03381963 · 2017-04-01

Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in CancerNCT02744092 · 2016-12-13

Thrombosis Outcomes in Pediatric Venous ThromboembolismNCT03068923 · 2016-05-01

Time of Treatment With LMWH in Cancer Patients With Thromboembolic DiseaseNCT03134820 · 2015-12-15

Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous ThromboembolismNCT02585713 · 2015-11-20

Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic SurgeryNCT02334007 · 2015-09-01

Non Interventional Study of the Validation of the Ottawa Score in Cancer Patients With Venous Thromboembolism (VTE)NCT03099031 · 2015-05-01

Venous Thromboembolic Complications in Ovarian CancerNCT02480790 · 2014-11-01

Follow-up in Rivaroxaban Patients in Setting of ThromboembolismNCT02248610 · 2014-11-01

Anticoagulation Length in Cancer Associated ThrombosisNCT01817257 · 2013-12-01

Comparing Anti-XA Levels in Post-Cesarean Patients Undergoing Enoxaparin ThromboprophylaxisNCT02070237 · 2013-08-01

Implementing a Tool to Identify Risk for Venous Thromboembolism in Cancer PatientsNCT01602432 · 2012-11-01

Pro-coagulant Markers and Anticoagulant Failure in Cancer Patients at Risk for Recurrence of Venous ThromboembolismNCT01602445 · 2012-07-01

Collaborative Healthcare Professionals Approach in Monitoring of Patient Centered Outcomes Through PathwaysNCT01561885 · 2012-03-01

Safety and Efficacy of Lean Body Weight-based IV Heparin Dosing in Obese/Morbidly Obese PatientsNCT01363193 · 2011-07-01

The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic SurgeryNCT01267305 · 2011-01-01

Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary EmbolismNCT01164046 · 2010-08-01

Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer PatientsNCT00966277 · 2010-04-01

A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer PatientsNCT00876915 · 2009-07-01

Obstructive Sleep Apnea and Venous ThromboembolismNCT01051297 · 2009-03-01

Screening for Occult Malignancy in Patients With Idiopathic Venous ThromboembolismNCT00773448 · 2008-09-01

Venous Thromboembolism and Haemostatic Disturbances in Patients With Upper Gastrointestinal CancerNCT00660205 · 2008-02-01

Study on the Clinical Course Of Pulmonary EmbolismNCT01781858 · 2008-01-01

Fondaparinux (Arixtra) With Chemotherapy for Advanced Non-Small Cell Lung CancerNCT00476216 · 2007-09-01

Dalteparin vs Unfractionated Heparin For The Prevention Of Venous Thromboembolism (VTE) In Hospitalized Acutely Ill Medical PatientsNCT00445328 · 2007-06-01

Epidemiology of Venous ThromboembolismNCT00456196 · 2006-04-01

Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung CarcinomaNCT00192829 · 2005-06-01

CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation)NCT00219973 · 2005-05-01

Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour PatientsNCT00135876 · 2002-10-01

Long-term Active Surveillance Study for Oral Contraceptives (LASS)NCT00676065 · 2001-02-01

Common interventions

Leading sponsors

Ottawa Hospital Research Institute4 Brigham and Women's Hospital3 Anthos Therapeutics, Inc.2 McMaster University2 University of Calgary2 Academic and Community Cancer Research United1 Alliance Foundation Trials, LLC.1 Assistance Publique - Hôpitaux de Paris1 Beijing Chao Yang Hospital1 Cardiff University1 Center for Epidemiology and Health Research, Germany1 Chinese University of Hong Kong1 Delos Clinical1 Fondazione Policlinico Universitario Agostino Gemelli IRCCS1 Guangdong Provincial People's Hospital1

Trial status mix

COMPLETED27

TERMINATED11

UNKNOWN6

RECRUITING5

ACTIVE_NOT_RECRUITING2

NOT_YET_RECRUITING2

WITHDRAWN2

Phase mix

PHASE311

NA9

PHASE46

PHASE14

PHASE23

EARLY_PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.